Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Acquisitions (2017 - 2024)

Historic Acquisitions for Avalo Therapeutics (AVTX) over the last 3 years, with Q1 2024 value amounting to $356000.0.

  • Avalo Therapeutics' Acquisitions changed N/A to $356000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $356000.0, marking a year-over-year change of. This contributed to the annual value of $356000.0 for FY2024, which is N/A changed from last year.
  • Avalo Therapeutics' Acquisitions amounted to $356000.0 in Q1 2024.
  • Avalo Therapeutics' Acquisitions' 5-year high stood at $356000.0 during Q1 2024, with a 5-year trough of $356000.0 in Q1 2024.